Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
74.4 USD | -0.81% | +5.56% | -9.28% |
Nov. 15 | Cigna Remains Open to Large-Scale M&A, RBC Says | MT |
Nov. 15 | Centene Names Susan Smith COO | MT |
Financials (USD)
Sales 2023 * | 151B | Sales 2024 * | 142B | Capitalization | 39.74B |
---|---|---|---|---|---|
Net income 2023 * | 2.89B | Net income 2024 * | 2.92B | EV / Sales 2023 * | 0,28x |
Net Debt 2023 * | 2.8B | Net Debt 2024 * | 2.3B | EV / Sales 2024 * | 0,30x |
P/E ratio 2023 * | 14,3x | P/E ratio 2024 * | 13,2x | Employees | 74,300 |
Yield 2023 * | - | Yield 2024 * | - | Free-Float | 86.53% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
1 day | -0.81% | ||
1 week | +5.56% | ||
Current month | +0.98% | ||
1 month | +3.56% | ||
3 months | +17.50% | ||
6 months | +11.49% | ||
Current year | -9.28% |
1 week
73.49
75.31

1 month
68.15
75.31

Current year
60.83
83.61

1 year
60.83
87.79

3 years
57.16
98.53

5 years
41.62
98.53

10 years
13.53
98.53

Managers | Title | Age | Since |
---|---|---|---|
Sarah London
CEO | Chief Executive Officer | 42 | 2020 |
Andrew Asher
DFI | Director of Finance/CFO | 54 | 2021 |
Kenneth Fasola
PSD | President | 63 | 2022 |
Members of the board | Title | Age | Since |
---|---|---|---|
Monte Ford
BRD | Director/Board Member | 63 | Nov. 11 |
Director/Board Member | 70 | 2021 | |
Chairman | 64 | 2006 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.17% | 821 M€ | -3.69% | - | |
3.10% | 41 M€ | 0.00% | - | |
3.09% | 44 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
23-12-06 | 74.4 | -0.81% | 2,153,330 |
23-12-05 | 75.01 | +1.32% | 3,012,374 |
23-12-04 | 74.03 | -1.14% | 2,348,672 |
23-12-01 | 74.88 | +1.63% | 3,888,414 |
23-11-30 | 73.68 | +4.54% | 6,144,627 |
Delayed Quote Nyse, December 06, 2023 at 04:00 pm EST
More quotes
Centene Corporation specializes in health services. Revenues break down by activity as follows:
- development of health insurance programs (93.4%): primarily for children, pregnant women, blind and disabled persons;
- specialized services (6.6%): pharmaceutical services (claims processing, pharmacy network management, mail order sales, home delivery, analysis and clinical consulting services, etc.), health care services by education and empowerment (behavioral orientation programs and welfare, nursing advice, etc.), eye and dental care services, home care services, development of health care management solutions, etc.
Sector
Managed Healthcare
Calendar
2023-12-12
- Investor Day
Trading Rating :
Investor Rating :
ESG Refinitiv :
B-
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
74.4USD
Average target price
83.08USD
Spread / Average Target
+11.67%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.28% | 39 745 M $ | |
+3.65% | 508 B $ | |
-6.76% | 112 B $ | |
-22.29% | 75 347 M $ | |
-5.54% | 59 561 M $ | |
+9.87% | 21 152 M $ | |
+17.01% | 3 493 M $ | |
-32.48% | 1 501 M $ | |
+1.99% | 462 M $ |